Literature DB >> 25580566

Children with epilepsy and anxiety: Subcortical and cortical differences.

Jana E Jones1, Daren C Jackson, Karlee L Chambers, Kevin Dabbs, David A Hsu, Carl E Stafstrom, Michael Seidenberg, Bruce P Hermann.   

Abstract

OBJECTIVE: Using a hypothesis-driven approach, subcortical and cortical regions implicated in anxiety disorders in the general population were examined in children with recent-onset epilepsy with versus without anxiety compared to controls. This study reports frequency of anxiety disorders while examining familial, clinical, and demographic variables associated with anxiety in children with epilepsy.
METHOD: Participants included 88 children with epilepsy aged 8-18 years: 25 with a current anxiety disorder and 63 children with epilepsy and no current anxiety disorder. Forty-nine controls without anxiety disorders were included. T1 volumetric magnetic resonance imaging (MRI) scans were collected; subcortical volumes and cortical thickness were computed using the FreeSurfer image analysis suite. Analyses focused on adjusted measures of subcortical volumes and cortical thickness.
RESULTS: Relative to controls, larger left amygdala volumes were found in the Epilepsy with Anxiety group compared to the Epilepsy without Anxiety group (p = 0.027). In the hippocampus, there were no significant differences between groups. Examination of cortical thickness demonstrated that the Epilepsy with Anxiety group showed thinning in left medial orbitofrontal (p = 0.001), right lateral orbitofrontal (p = 0.017), and right frontal pole (p = 0.009). There were no differences between groups in age, sex, IQ, age of onset, medications, or duration of epilepsy. There were more family members with a history of anxiety disorders in the Epilepsy with Anxiety group compared to the Epilepsy without Anxiety group (p = 0.005). SIGNIFICANCE: Anxiety is a common psychiatric comorbidity in children with recent-onset epilepsy with volumetric enlargement of the amygdala and thinner cortex in orbital and other regions of prefrontal cortex, suggesting structural abnormalities in brain regions that are part of the dysfunctional networks reported in individuals with anxiety disorders in the general population. These findings are evident early in the course of epilepsy, are not related to chronicity of seizures, and may be linked to a family history of anxiety and depressive disorders. Wiley Periodicals, Inc.
© 2015 International League Against Epilepsy.

Entities:  

Keywords:  Amygdala; Anxiety disorders; Pediatric Epilepsy

Mesh:

Year:  2015        PMID: 25580566      PMCID: PMC4340751          DOI: 10.1111/epi.12832

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  36 in total

Review 1.  Emotion, plasticity, context, and regulation: perspectives from affective neuroscience.

Authors:  Richard J Davidson; Daren C Jackson; Ned H Kalin
Journal:  Psychol Bull       Date:  2000-11       Impact factor: 17.737

2.  Lifetime co-morbidity of DSM-IV disorders in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A).

Authors:  R C Kessler; S Avenevoli; K A McLaughlin; J Greif Green; M D Lakoma; M Petukhova; D S Pine; N A Sampson; A M Zaslavsky; K Ries Merikangas
Journal:  Psychol Med       Date:  2012-01-25       Impact factor: 7.723

3.  Reformulating PTSD for DSM-V: life after Criterion A.

Authors:  Chris R Brewin; Ruth A Lanius; Andrei Novac; Ulrich Schnyder; Sandro Galea
Journal:  J Trauma Stress       Date:  2009-09-09

Review 4.  Anxiety symptoms in epilepsy: salient issues for future research.

Authors:  Hamada Hamid; Alan B Ettinger; Marco Mula
Journal:  Epilepsy Behav       Date:  2011-07-08       Impact factor: 2.937

5.  Familial clustering of epilepsy and behavioral disorders: evidence for a shared genetic basis.

Authors:  Dale C Hesdorffer; Rochelle Caplan; Anne T Berg
Journal:  Epilepsia       Date:  2011-12-22       Impact factor: 5.864

6.  A pilot study of amygdala volumes in pediatric generalized anxiety disorder.

Authors:  M D De Bellis; B J Casey; R E Dahl; B Birmaher; D E Williamson; K M Thomas; D A Axelson; K Frustaci; A M Boring; J Hall; N D Ryan
Journal:  Biol Psychiatry       Date:  2000-07-01       Impact factor: 13.382

7.  Amygdala reactivity in healthy adults is correlated with prefrontal cortical thickness.

Authors:  Lara C Foland-Ross; Lori L Altshuler; Susan Y Bookheimer; Matthew D Lieberman; Jennifer Townsend; Conor Penfold; Teena Moody; Kyle Ahlf; Jim K Shen; Sarah K Madsen; Paul E Rasser; Arthur W Toga; Paul M Thompson
Journal:  J Neurosci       Date:  2010-12-08       Impact factor: 6.167

8.  Depression and anxiety disorders in pediatric epilepsy.

Authors:  Rochelle Caplan; Prabha Siddarth; Suresh Gurbani; Rebecca Hanson; Ramen Sankar; W Donald Shields
Journal:  Epilepsia       Date:  2005-05       Impact factor: 5.864

9.  The structure of genetic and environmental risk factors for anxiety disorders in men and women.

Authors:  John M Hettema; Carol A Prescott; John M Myers; Michael C Neale; Kenneth S Kendler
Journal:  Arch Gen Psychiatry       Date:  2005-02

10.  Orbitofrontal cortex function and structure in depression.

Authors:  Wayne C Drevets
Journal:  Ann N Y Acad Sci       Date:  2007-09-13       Impact factor: 5.691

View more
  9 in total

Review 1.  Structural Image Analysis of the Brain in Neuropsychology Using Magnetic Resonance Imaging (MRI) Techniques.

Authors:  Erin D Bigler
Journal:  Neuropsychol Rev       Date:  2015-08-18       Impact factor: 7.444

2.  Structural Neuroimaging and Neuropsychologic Signatures in Children With Vertically Acquired HIV.

Authors:  Robert Paul; Wasana Prasitsuebsai; Neda Jahanshad; Thanyawee Puthanakit; Paul Thompson; Linda Aurpibul; Rawiwan Hansudewechakul; Pope Kosalaraksa; Suparat Kanjanavanit; Chaiwat Ngampiyaskul; Wicharn Luesomboon; Sukalaya Lerdlum; Mantana Pothisri; Pannee Visrutaratna; Victor Valcour; Talia M Nir; Arvin Saremi; Stephen Kerr; Jintanat Ananworanich
Journal:  Pediatr Infect Dis J       Date:  2018-07       Impact factor: 2.129

3.  Evaluation of cortical thickness and brain volume on 3 Tesla magnetic resonance imaging in children with frontal lobe epilepsy.

Authors:  Feride Kural Rahatli; Taner Sezer; Arzu Ceylan Has; Ahmet Muhtesem Agildere
Journal:  Neurol Sci       Date:  2019-12-04       Impact factor: 3.307

4.  Cortical thickness asymmetries and surgical outcome in neocortical epilepsy.

Authors:  David O Kamson; Vinod K Pilli; Eishi Asano; Jeong-Won Jeong; Sandeep Sood; Csaba Juhász; Harry T Chugani
Journal:  J Neurol Sci       Date:  2016-06-29       Impact factor: 3.181

5.  Cortical Thickness and Subcortical Gray Matter Volume in Pediatric Anxiety Disorders.

Authors:  Andrea L Gold; Elizabeth R Steuber; Lauren K White; Jennifer Pacheco; Jessica F Sachs; David Pagliaccio; Erin Berman; Ellen Leibenluft; Daniel S Pine
Journal:  Neuropsychopharmacology       Date:  2017-04-24       Impact factor: 7.853

6.  Cortical thickness and sulcal depth: insights on development and psychopathology in paediatric epilepsy.

Authors:  Duygu Tosun; Prabha Siddarth; Jennifer Levitt; Rochelle Caplan
Journal:  BJPsych Open       Date:  2015-10-22

7.  Disruptions in cortico-subcortical covariance networks associated with anxiety in new-onset childhood epilepsy.

Authors:  Camille Garcia-Ramos; Jack J Lin; Leonardo Bonilha; Jana E Jones; Daren C Jackson; Vivek Prabhakaran; Bruce P Hermann
Journal:  Neuroimage Clin       Date:  2016-10-23       Impact factor: 4.881

8.  Major Depressive Disorder Associated With Reduced Cortical Thickness in Women With Temporal Lobe Epilepsy.

Authors:  Mateus Henrique Nogueira; Luciana Ramalho Pimentel da Silva; José Carlos Vasques Moreira; Thiago Junqueira Ribeiro de Rezende; Tamires Araújo Zanão; Brunno Machado de Campos; Clarissa Lin Yasuda; Fernando Cendes
Journal:  Front Neurol       Date:  2020-01-17       Impact factor: 4.003

9.  Psychiatric Comorbidities in Children With ASD: Autism Centre Experience.

Authors:  Iva Ivanović
Journal:  Front Psychiatry       Date:  2021-06-09       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.